A5071458377- Cardiac, Anesthesia and Surgical Outcomes
- Acute Myocardial Infarction Research
- Cardiac Valve Diseases and Treatments
- Transplantation: Methods and Outcomes
- Antiplatelet Therapy and Cardiovascular Diseases
- Coronary Interventions and Diagnostics
- Mechanical Circulatory Support Devices
- Venous Thromboembolism Diagnosis and Management
- Health Systems, Economic Evaluations, Quality of Life
- Organ Transplantation Techniques and Outcomes
- Cardiac and Coronary Surgery Techniques
- Renal Transplantation Outcomes and Treatments
- Polyomavirus and related diseases
- Smoking Behavior and Cessation
- Cardiac Ischemia and Reperfusion
- Obesity, Physical Activity, Diet
- Aortic aneurysm repair treatments
- Cardiac Arrest and Resuscitation
- Viral-associated cancers and disorders
- Healthcare Operations and Scheduling Optimization
- Cardiac Health and Mental Health
- Pediatric health and respiratory diseases
- Cardiac Structural Anomalies and Repair
- Cardiac Imaging and Diagnostics
- Tumors and Oncological Cases
Sahlgrenska University Hospital
2001-2018
University of Gothenburg
2008-2014
Abbott (Sweden)
2013
Medtronic (Canada)
2013
We investigated early outcomes in patients with end-stage pulmonary disease bridged extracorporeal membrane oxygenation (ECMO) the intention to perform lung transplantation (LTx). ECMO was used as a bridge LTx 20 between 2005 and 2013. Most suffered from rapid progress of most failed stabilize on mechanical ventilation. Sixteen (10 males, median age 42 years, range 25–59) underwent after support for 9 (range 1–229) days. were not waiting list while receiving ECMO, but being assessed 6 1–72)...
Ticagrelor reduces thrombotic events compared with clopidogrel in patients acute coronary syndrome, but may also increase bleeding complications. Coronary artery bypass grafting (CABG)-related complications have not previously been and ticagrelor-treated outside the controlled environment of clinical trials. Four hundred five consecutive CABG syndrome were included a prospective observational study. The treated aspirin ticagrelor (n = 173) or 232). Ticagrelor/clopidogrel was discontinued 5...
OBJECTIVE: Dual antiplatelet therapy with ticagrelor and aspirin is associated an increased risk of perioperative bleeding complications. Current guidelines recommend therefore discontinuation 5 days before surgery to allow sufficient recovery platelet function. It not known how the time varies between individual patients after ticagrelor. METHODS: Twenty-five accepted for urgent coronary artery bypass treated were included in a prospective observational study. Platelet aggregation was...
Previous large studies have shown that solid organ transplant (SOT) patients an increased risk of developing malignancies. Few compared the prognosis for SOT who develop cancer with non-transplanted patients. In this study we investigated oral and lip in also relative survival between non-SOT cancer.From patient registers at Transplant Institute Sahlgrenska University Hospital, records 4604 from 1965 to 2010 were collected. These linked nationwide Swedish Cancer Register those normal...
There are gender differences in clinical presentation, treatment and outcome of patients with coronary artery disease. We investigated whether there is also a difference terms mortality risk on the waiting list accepted for bypass grafting (CABG).All our elective CABG 1995-1999 (1303 women 4561 men) were included. Prospectively registered preoperative characteristics compared between men women. Hazard functions death calculated using Poisson regression.At acceptance, older (68+/-9 vs 65+/-9...
Organ transplant recipients (OTRs) have a very high risk of developing cutaneous squamous cell carcinoma (cSCC). Immunosuppressed OTRs may higher proportion poorly differentiated cSCC than non-OTRs.The aim this study was to investigate the degree differentiation cSCCs in compared with immunocompetent individuals.Data from Swedish Cancer Registry were crosschecked data Transplant registry Institute at Sahlgrenska University Hospital Gothenburg, Sweden. All diagnosis cSCC, basosquamous...
According to guide-lines, coronary bypass surgery improves survival in high risk patients. The evidence for this is more than 20 years old and may be questioned. Long waiting lists are detrimental but offer the possibility compare of death before after surgery. We hypothesized that lower operation patients a recent cohort.Death hazard functions were calculated by use Poisson regression scheduled between 1 Jan 1995 31 July 2005. analyses performed two states: 1) period triage until admission...
An organ allocation policy, in which hearts from blood group-O donors are used to transplant recipients with other groups (ABO-compatible, non-identical transplantations), may affect patients on the waiting list. We investigated how group affiliation influences potential In case of O, fewer were transplanted, list mortality was higher and time transplantation longer. Patients O awaiting cardiac affected considerably by an policy ABO-compatible, transplantations performed.
Objectives: Ticagrelor reduces thrombotic events compared to clopidogrel in patients with acute coronary syndrome but may also increase bleeding complications. Coronary artery bypass graft (CABG)-related complications clopidogrel- and ticagrelor-treated have not previously been outside the controlled environment of clinical trials. Methods: Two-hundred eighty consecutive CABG an were included a prospective study. The treated acetylsalicylic acid ticagrelor (n = 96) or 184)....
Relationship Disclosure: L.S. Annest is an